Back in 2023, artificial intelligence in healthcare was still a tough sell. Doctors were curious, investors were cautious, and ChatGPT had yet to become part of daily life (if you can believe it). When South Florida-based Delorean AI landed its first major healthcare client, the company was asking providers to trust technology that claimed it could predict health problems before they happened.
Three years later, that pitch sounds a lot less radical.
Founded by entrepreneur Severence MacLaughlin, Delorean AI has spent the last few years scaling a platform designed to help healthcare providers spot future health risks before they become medical emergencies. The company has raised more than $10 million, expanded nationwide, published research on chronic disease management, and recently signed a collaboration agreement with the American Heart Association.
What began with kidney disease management is now deployed across dialysis centers, nephrology practices, skilled nursing facilities, and other healthcare settings around the country. Delorean’s technology analyzes patient data to predict future complications, hospitalizations, and disease progression, allowing physicians to act earlier.
“We give them the entire movie of your life health versus a snapshot,” CEO MacLaughlin, who holds a Ph.D, told Refresh Miami.
While much of the AI conversation focuses on tools like ChatGPT, MacLaughlin argues that healthcare requires a different type of intelligence. Generating text is one thing – but predicting a future medical event, then giving clinicians useful next steps, is another.
“I call it the Netscape effect,” MacLaughlin said, referencing the early days of the internet. “People could touch it and feel it. That really was what happened with OpenAI.”
Delorean also discovered something important about its business model. The company originally assumed insurance companies would be its main customers. But insurers were not always positioned to act on predictions at the point of care.
“We built our technology assuming that our end user or buyer would be the insurance companies,” MacLaughlin said. “What we found is that we were incorrect.”
So Delorean pivoted toward providers. Doctors, unlike insurers, can change medications, order tests, schedule follow-ups, and intervene before risks become crises.
“We are bringing all the information past, present, and future in one easy digestible format that they can make the best decision,” he said.
The company now has roughly 20 team members, with plans to keep hiring. It has also expanded beyond kidney disease into cardiovascular health, mental health, COPD, transplant AI, and other areas.
For MacLaughlin, the broader AI story is still early. He expects continued growth in large language models, agentic systems, computer vision, and sound recognition, especially in areas like medicine and industrial monitoring.
“I think you’re going to see a growth in sound recognition,” he said. “Sound is mathematical. It’s even more mathematical than vision.”
MacLaughlin remains bullish on South Florida as a place to build. “Miami, Palm Beach, Coral Gables… you name it,” he said. “South Florida’s the place to be.”
READ MORE IN REFRESH MIAMI:
- DeLorean raises $7.55M to enable enterprise companies to unlock AI innovation
- Sofya wants to turn physician vibe coding into real healthcare AI
- Miami startup CVRD Health lands $5M seed round to streamline federal contractor benefits
- Housing became a healthcare problem, so Upside built a business around it
- The healthcare system is bleeding money. Predictive AI is the only way to stop it.
- Blockchain Rx! Solum Global’s cure for healthcare’s payment headaches
- Osigu secures $10M from Eos Ventures to reshape healthcare payments in Latin America
- Delorean AI wants to give doctors something they’ve never had: A glimpse into the future – June 24, 2026
- Hut 8 is betting Miami can become an AI talent powerhouse – June 23, 2026
- Latitudes wants to make West Palm Beach a company-building engine for the New York–South Florida tech corridor – June 22, 2026
